D'Angio Paul 4
4 · NexImmune, Inc. · Filed Jun 15, 2022
Insider Transaction Report
Form 4
NexImmune, Inc.NEXI
D'Angio Paul
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-06-13+61,678→ 61,678 totalExercise: $1.82From: 2023-06-13Exp: 2032-06-12→ Common Stock (61,678 underlying)